Cell Line Genetics, LLC (CLG), a privately held company based in Madison, Wisconsin company, was founded to provide services and products to support research institutions, as well as biotechnology and pharmaceutical companies focused on Embryonic Stem Cell and Cancer Research.
Under the scientific leadership of renowned clinical cytogeneticist Dr. Lorraine F. Meisner, CLG brings together a renowned team of experts to provide quality assurance services, clinical cancer testing and DNA/genotyping solutions, while developing a foundation for custom services and products.
Management Team :
Dr Lorraine Faxon Meisner, PhD - Chief Scientific Officer
Dr. Meisner is Emeritus Professor and Director of the Cytogenetics Laboratory for the University of Wisconsin. Dr. Meisner has actively pursued research into mechanisms of genetic damage leading to cancer and birth defects, leading to over 200 publications in peer-reviewed journals. Under her leadership, the University of Wisconsin Cytogenetics Laboratory became one of the largest university based clinical laboratories in the country.
It was under her direction that the chromosomes of the first embryonic stem cell lines derived by Dr. James Thomson were first studied, and the Thomson technology led to several patents which provide the basis of all embryonic stem cell work in the world. Dr. Meisner is one of the world's authorities in clinical cytogenetics and a sought after speaker and researcher. Dr. Meisner is Board Certified and a founding member of the American College of Medical Genetics.
Ms. Julie A. Johnson, MS, CPSp(CG) - Director of Laboratory Operations/Cell Line Coordinator
Ms. Johnson brings to Cell Line Genetics over 25 years of relevant experience as a cytogenetics technologist and laboratory supervisor in both academic and commercial settings, overseeing the FISH laboratory at the Wisconsin State Laboratory of Hygiene at the University of Wisconsin-Madison for the last 8 years. She holds a master's degree in cytogenetics and is certified as a clinical specialist in cytogenetics by the National Certification Agency for Laboratory Personnel.
In 1998 Ms. Johnson and Dr. Meisner founded the Cell Line Characterization Program at the WSLH. The program gained national recognition in the ES cell research community, with renowned clients such as James Thomson PhD, (University of Wisconsin/WiCell), Steve Stice Ph.D. and Maya Mitalipova Ph.D., (University of Georgia-Athens), Don Wolff MD., PhD and Shoukhrat Mitalipova Ph.D., (Oregon Regional Primate Center) and Dr. Robert Lanza (Advanced Cell Technologies, Inc).
Dr. Mario L. Salguero, M.D., Ph.D. - Director - DNA Diagnostics, Mexican Operations Dr. Mario L. Salguero is a Researcher and Professor at the University of Guadalajara and a Visiting Professor at the University of Wisconsin-Madison. With over 9 years of experience in DNA fingerprinting and genetic polymorphism analysis on research and clinical scenarios, Dr. Salguero has received a number of honors including the Exemplary Research Award of the International Association for Hepatic Studies.
Dr. Salguero is a Medicine, Molecular Biology and DNA Court Expert for both the state of Jalisco and the Supreme Court of Justice of Mexico. His research has been published in local and international scientific peer-reviewed journals, and is presently a contributing textbook author. Dr. Salguero is responsible for establishing an academic exchange agreement between the University of Guadalajara and the University of Wisconsin, made official on February 2005.
Mr. Roberto Herrera - Managing Director / Business Development
Mr. Herrera's career has been characterized by the rapid building, development and management of both large and small organizations. Rob played a lead role in the technical and operational phases of the NationsBank/Montgomery and Bank of America/NationsBank mergers, progressing to the rank of Senior VP of Fixed Income Technology and Operations.
Following Bank of America, Mr. Herrera went on to senior management positions in Catapulse (acquired by Rational Software) and Capstan Systems (acquired by Qiva Systems). Since then, Rob has turned his entrepreneurial interests towards the pharmaceutical and biotech industry and is currently involved in 2 ongoing ventures in those areas.
Dr. Neal First - Director, Scientific Advisor
Dr. Neal First is L.E. Casida Professor of Reproductive Biology and Animal Technology at UW-Madison, associated with the Department of Animal Science in the College of Agricultural and Life Sciences and with the Department of Obstetrics and Gynecology in the School of Medicine. In 1987, Dr. First proved that cattle could be cloned when "Fusion" and "Copy," the first cloned cattle in the world, were born on the Madison campus. Genetic carbon copies, the calves illustrated the potential of harnessing the tools of modern biology to produce custom-built herds of superior livestock.
Dr. First has launched 2 previous companies based on his work, one of which was successfully acquired by Cardinal Health. He is a member of the prestigious National Academy of Sciences and The National Advisory Board on Ethics in Reproduction.
|
